BACKGROUND: Preferential bony metastasis of human prostate cancer (PCa) cells contributes to disease mortality and morbidity. Local factors in bone stromal extracellular matrix microenvironment affect tumor growth through paracrine interactions between tumor and stromal cells. METHODS: Using co-culture and medium transfer, we used several methods to assess interactions between PCa and bone stromal cells using three PCa cell lines: PC3, LNCaP, and the LNCaP derivative, C4-2B. RESULTS: Co-culture of LNCaP and C4-2B cells with bone marrow stromal cell lines, HS27a and HS5, decreased cell number, as did culture with conditioned medium (CM) harvested from these two cell lines suggesting a soluble paracrine factor was responsible. PC3 cell growth was unaffected. CM harvested from bone stromal cell lines triggered apoptosis in LNCaP and C4-2B cell lines, but not in PC3 cells. Surviving C4-2B cells grown in bone stromal cell CM over several days were growth arrested, suggesting presence of a growth inhibitor. Apoptosis induced by CM was dose-dependent. Flow cytometry demonstrated that over a 5-day culture period in stromal cell CM, LNCaP, and C4-2B cell lines, but not PC3 cells, underwent greater apoptosis than parallel cultures in SF medium. The LNCaP and C4-2B cells showed morphology and biomarker expression consistent with transdifferentiation towards a neuroendocrine phenotype after exposure to stromal cell CM. CONCLUSIONS: The reactive bone stromal microenvironment initially is hostile to PCa cells producing widespread apoptosis. Activation of transdifferentiation in a subset of apoptotic resistant cells may support phenotypic adaptation during disease progression in bone, eventually favoring lethal disease.
BACKGROUND: Preferential bony metastasis of human prostate cancer (PCa) cells contributes to disease mortality and morbidity. Local factors in bone stromal extracellular matrix microenvironment affect tumor growth through paracrine interactions between tumor and stromal cells. METHODS: Using co-culture and medium transfer, we used several methods to assess interactions between PCa and bone stromal cells using three PCa cell lines: PC3, LNCaP, and the LNCaP derivative, C4-2B. RESULTS: Co-culture of LNCaP and C4-2B cells with bone marrow stromal cell lines, HS27a and HS5, decreased cell number, as did culture with conditioned medium (CM) harvested from these two cell lines suggesting a soluble paracrine factor was responsible. PC3 cell growth was unaffected. CM harvested from bone stromal cell lines triggered apoptosis in LNCaP and C4-2B cell lines, but not in PC3 cells. Surviving C4-2B cells grown in bone stromal cell CM over several days were growth arrested, suggesting presence of a growth inhibitor. Apoptosis induced by CM was dose-dependent. Flow cytometry demonstrated that over a 5-day culture period in stromal cell CM, LNCaP, and C4-2B cell lines, but not PC3 cells, underwent greater apoptosis than parallel cultures in SF medium. The LNCaP and C4-2B cells showed morphology and biomarker expression consistent with transdifferentiation towards a neuroendocrine phenotype after exposure to stromal cell CM. CONCLUSIONS: The reactive bone stromal microenvironment initially is hostile to PCa cells producing widespread apoptosis. Activation of transdifferentiation in a subset of apoptotic resistant cells may support phenotypic adaptation during disease progression in bone, eventually favoring lethal disease.
Authors: Robert A Sikes; Brian E Nicholson; Kenneth S Koeneman; N Magnus Edlund; Eric A Bissonette; Michael J Bradley; George N Thalmann; Marco G Cecchini; Kenneth J Pienta; Leland W K Chung Journal: Int J Cancer Date: 2004-07-01 Impact factor: 7.396
Authors: Megan A Chang; Micaela Morgado; Curtis R Warren; Cimona V Hinton; Mary C Farach-Carson; Nikki A Delk Journal: Prostate Date: 2013-09-30 Impact factor: 4.104
Authors: Andrew Farach; Yi Ding; MinJae Lee; Chad Creighton; Nikki A Delk; Michael Ittmann; Brian Miles; David Rowley; Mary C Farach-Carson; Gustavo E Ayala Journal: Prostate Date: 2016-07-12 Impact factor: 4.104
Authors: Daniel W Sherbenou; Blake T Aftab; Yang Su; Christopher R Behrens; Arun Wiita; Aaron C Logan; Diego Acosta-Alvear; Byron C Hann; Peter Walter; Marc A Shuman; Xiaobo Wu; John P Atkinson; Jeffrey L Wolf; Thomas G Martin; Bin Liu Journal: J Clin Invest Date: 2016-11-14 Impact factor: 14.808
Authors: Andrew A Jarrah; Martina Schwarskopf; Edward R Wang; Thomas LaRocca; Ashwini Dhume; Shihong Zhang; Lahouria Hadri; Roger J Hajjar; Alison D Schecter; Sima T Tarzami Journal: Apoptosis Date: 2018-01 Impact factor: 4.677
Authors: Shayna E Thomas-Jardin; Mohammed S Kanchwala; Joan Jacob; Sana Merchant; Rachel K Meade; Nagham M Gahnim; Afshan F Nawas; Chao Xing; Nikki A Delk Journal: Prostate Date: 2018-03-11 Impact factor: 4.104
Authors: Daniel W Sherbenou; Yang Su; Christopher R Behrens; Blake T Aftab; Olivia Perez de Acha; Megan Murnane; Shelby C Bearrows; Byron C Hann; Jeffery L Wolf; Thomas G Martin; Bin Liu Journal: Clin Cancer Res Date: 2020-09-11 Impact factor: 12.531
Authors: M A Chang; V Patel; M Gwede; M Morgado; K Tomasevich; E L Fong; M C Farach-Carson; Nikki A Delk Journal: J Cell Biochem Date: 2014-12 Impact factor: 4.429